Erika Song | Influence 100
The Holmes Report becomes PRovokeMore here

Erika Song 

Director of Marketing Operations 
Gilead Sciences
US

 

 

 As the maker of an anti-viral drug effective against Covid-19, Gilead Sciences has been at the forefront of the global pandemic. According to one poll, remdesivir has even boosted the company’s reputation among the public. Even with the promise of remdesivir, the pandemic has provided some challenges for the pharma company. For one, sales fell 10% in Q2 because the coronavirus has diminished demand for some of its other drugs.

This all means that Erika Song is having a relatively unprecedented experience. She’s handling marketing for a drug company that produces a promising therapy for a deadly virus that is currently uncontained in the United States and also impacting the rest of the world at varying degrees of severity. She’s well-positioned for this endeavor, as Song has more than two decades of experience in marketing and marketing operations, strategic sourcing, client relationship management, business development and change management. On her LinkedIn profile, Song says that she is “highly effective in challenging work environments building high performing teams and successful partnerships, both direct and cross-functional.” This, it seems, is her moment.